0001209191-19-003804.txt : 20190115
0001209191-19-003804.hdr.sgml : 20190115
20190115185648
ACCESSION NUMBER: 0001209191-19-003804
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190101
FILED AS OF DATE: 20190115
DATE AS OF CHANGE: 20190115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Fred E
CENTRAL INDEX KEY: 0001339358
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 19527917
MAIL ADDRESS:
STREET 1: 301 COMMERCE STREET
STREET 2: SUITE 3300
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2019-01-01
2019-01-10
0
0001668243
UroGen Pharma Ltd.
URGN
0001339358
Cohen Fred E
C/O UROGEN PHARMA LTD.
9 HA?TA?ASIYA STREET
RA?ANANA
L3
4365007
ISRAEL
1
0
0
0
Stock Option (right to buy)
16.99
2027-05-15
Ordinary Shares
40000
D
Stock Option (right to buy)
59.23
2028-06-04
Ordinary Shares
10000
D
6.25% of the shares underlying the stock option vested on each of August 15, 2017, November 15, 2017 and February 15, 2018; 31.25% of the shares vested May 15, 2018 and the remaining shares will vest in equal quarterly installment commencing 3 months after May 15, 2018.
The information in column 3 and column 4 were inadvertently transposed on the initial Form 3 filing.
25% of the shares underlying the stock option vested on each of September 4, 2018 and December 4, 2018 and the remaining shares will in two equal installments on March 4, 2019 and June 4, 2019.
/s/ Peter Pfreundschuh, Attorney-in-Fact
2019-01-15